We’re excited to announce the launch of our novel clinical trial data-sharing and analytics platform. Vivli will help speed up science and discovery and allow researchers to move faster toward new treatments.

Vivli is a nonprofit organization – a neutral site – housing the new platform that enables the integration of large scale clinical trial data sets provided by industry, academia, and nonprofits. The secure cloud-based platform features a robust search engine. This makes clinical trial data accessible for researchers worldwide, regardless of who sponsored the research or where it took place.

This launch includes more than 2500 studies from 15 organizations with data from more than 98 countries across numerous disease areas, including diabetes, Alzheimer’s and malaria, and representing the contributions of more than 1,300,000 trial participants.

We invite you to watch the video of our launch event, featuring:
• Rebecca Li, Vivli,
• Paul Slater, Microsoft,
• Ida Sim, UCSF and Vivli

The discussions also include testimonials from:
• Dr. Ara Tahmassian, Harvard University
• Jessica Scott, GlaxoSmithKline
• Gina Agiostratidou, the Leona M. and Harry B. Helmsley Charitable Trust
• Steven Kern, the Bill and Melinda Gates Foundation.

Vivli welcomed representatives from our fifteen Founding Member organizations: AbbVie, Aegerion Pharmaceuticals, Biogen, BioLINCC, Critical Path Institute, Duke University, GlaxoSmithKline, Harvard University, ImmPort, Johns Hopkins University, Pfizer, Project Data Sphere, Takeda, the Helmsley Charitable Trust, and UCSF.